171 related articles for article (PubMed ID: 8587166)
1. [Antimicrobial activities of clavulanic acid/amoxicillin against freshly isolated clinical strains from outpatients].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Dec; 48(12):1920-34. PubMed ID: 8587166
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Sep; 46(9):781-93. PubMed ID: 8254898
[TBL] [Abstract][Full Text] [Related]
3. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial activities of clavulanic acid/ticarcillin against clinical isolates].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Dec; 48(12):1899-905. PubMed ID: 8587164
[TBL] [Abstract][Full Text] [Related]
6. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
[TBL] [Abstract][Full Text] [Related]
8. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric sinusitis].
Sugita R; Komatsu N; Deguchi K; Okano K; Naito M; Yoshida Y; Watanabe H; Senba T; Harada S; Fukamoto K; Fujimaki Y
Jpn J Antibiot; 1999 Oct; 52(10):613-27. PubMed ID: 10638457
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial activity for clinical isolates from pediatric patients of clavulanic acid/amoxicillin (1: 14) -outcomes of special drug use investigation on antibacterial activity (annual changes)].
Ishida A; Hasegawa N; Okano H; Hara T; Yoshida P
Jpn J Antibiot; 2013 Jun; 66(3):141-58. PubMed ID: 24167843
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial activities of sultamicillin against clinical isolates from upper respiratory tract infections].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Sep; 41(9):1194-204. PubMed ID: 3266508
[TBL] [Abstract][Full Text] [Related]
12. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Haruta T; Kuroki S; Okura K; Kobayashi Y
Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
14. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
[TBL] [Abstract][Full Text] [Related]
15. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
[TBL] [Abstract][Full Text] [Related]
16. [In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
Jpn J Antibiot; 1986 Mar; 39(3):842-52. PubMed ID: 3488425
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Liljequist BO; Gezelius L
Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
[TBL] [Abstract][Full Text] [Related]
18. Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.
Thorburn CE; Molesworth SJ; Sutherland R; Rittenhouse S
Antimicrob Agents Chemother; 1996 Dec; 40(12):2796-801. PubMed ID: 9124843
[TBL] [Abstract][Full Text] [Related]
19. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]